Mitral valve surgery after a failed MitraClip procedure.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 12 05 2020
revised: 03 09 2020
accepted: 27 09 2020
pubmed: 23 11 2020
medline: 24 7 2021
entrez: 22 11 2020
Statut: ppublish

Résumé

Among patients undergoing transcatheter mitral valve repair with the MitraClip device, a relevant proportion (2-6%) requires open mitral valve surgery within 1 year after unsuccessful clip implantation. The goal of this review is to pool data from different reports to provide a comprehensive overview of mitral valve surgery outcomes after the MitraClip procedure and estimate in-hospital and follow-up mortality. All published clinical studies reporting on surgical intervention for a failed MitraClip procedure were evaluated for inclusion in this meta-analysis. The primary study outcome was in-hospital mortality. Secondary outcomes were in-hospital adverse events and follow-up mortality. Pooled estimate rates and 95% confidence intervals (CIs) of study outcomes were calculated using a DerSimionian-Laird binary random-effects model. To assess heterogeneity across studies, we used the Cochrane Q statistic to compute I2 values. Overall, 20 reports were included, comprising 172 patients. Mean age was 70.5 years (95% CI 67.2-73.7 years). The underlying mitral valve disease was functional mitral regurgitation in 50% and degenerative mitral regurgitation in 49% of cases. The indication for surgery was persistent or recurrent mitral regurgitation (grade >2) in 93% of patients, whereas 6% of patients presented with mitral stenosis. At the time of the operation, 80% of patients presented in New York Heart Association functional class III-IV. Despite favourable intraoperative results, in-hospital mortality was 15%. The rate of periprocedural cerebrovascular accidents was 6%. At a mean follow-up of 12 months, all-cause death was 26.5%. Mitral valve replacement was most commonly required because the possibility of valve repair was jeopardized, likely due to severe valve injury after clip implantation. Surgical intervention after failed transcatheter mitral valve intervention is burdened by high in-hospital and 1-year mortality, which reflects reflecting the high-risk baseline profile of the patients. Mitral valve replacement is usually required due to leaflet injury.

Identifiants

pubmed: 33221925
pii: 5998419
doi: 10.1093/icvts/ivaa270
pmc: PMC8906661
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

380-385

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Ann Thorac Surg. 2016 Mar;101(3):952-8
pubmed: 26505550
Ann Thorac Surg. 2005 Dec;80(6):2338-42
pubmed: 16305903
Tex Heart Inst J. 2014 Dec 01;41(6):609-12
pubmed: 25593525
Eur Heart J. 2016 Feb 21;37(8):703-12
pubmed: 26614824
Eur J Cardiothorac Surg. 2011 Dec;40(6):1521-6
pubmed: 21497508
Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):909-11
pubmed: 23864579
EuroIntervention. 2015 Jul;11(3):351-4
pubmed: 25136886
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Card Surg. 2009 Nov-Dec;24(6):677-81
pubmed: 19682161
Eur J Cardiothorac Surg. 2014 Jul;46(1):55-60
pubmed: 24321993
J Am Coll Cardiol. 2017 Nov 7;70(19):2315-2327
pubmed: 29096801
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):900-907
pubmed: 30698735
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
J Card Surg. 2015 May;30(5):414-8
pubmed: 25789567
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Ann Thorac Surg. 2013 May;95(5):e113-4
pubmed: 23608290
JACC Cardiovasc Interv. 2015 Sep;8(11):1480-1489
pubmed: 26404201
Eur J Cardiothorac Surg. 2012 Oct;42(4):739-40
pubmed: 22822104
J Card Surg. 2012 Sep;27(5):543-5
pubmed: 22755555
J Cardiothorac Surg. 2019 Apr 11;14(1):75
pubmed: 30971281
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1907-8
pubmed: 26604053
Eur J Cardiothorac Surg. 2012 Dec;42(6):1053
pubmed: 22659895
Catheter Cardiovasc Interv. 2014 Feb;83(2):297-302
pubmed: 23703973
J Artif Organs. 2015 Jun;18(2):177-80
pubmed: 25539700
Ann Thorac Surg. 2010 Jan;89(1):72-80; discussion p 80
pubmed: 20103209
EuroIntervention. 2016 Sep 18;12(Y):Y102-6
pubmed: 27640017

Auteurs

Francesco Melillo (F)

Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.

Luca Baldetti (L)

Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.

Alessandro Beneduce (A)

Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.

Eustachio Agricola (E)

Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Alberto Margonato (A)

Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Cosmo Godino (C)

Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH